Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Robinson

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Neurology|March 10, 2025
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular DiseasesErlan Sanchez, Gillian T Coughlan, Tim Wilkinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2022
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortKelly M Sunderland, Derek Beaton, Stephen R Arnott, et al.
The Journal of Clinical Investigation|July 3, 2019
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapyJason D Roberts, Nathaniel P Murphy, Robert M Hamilton, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Neurology|March 10, 2025
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular DiseasesErlan Sanchez, Gillian T Coughlan, Tim Wilkinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2022
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortKelly M Sunderland, Derek Beaton, Stephen R Arnott, et al.
The Journal of Clinical Investigation|July 3, 2019
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapyJason D Roberts, Nathaniel P Murphy, Robert M Hamilton, et al.
Pageof 5